283 results on '"Bay-Jensen, Anne-C."'
Search Results
2. Poor correlation between biomarkers and MRI-detected joint damage in a cross-sectional study of persons with nonsevere hemophilia A (DYNAMO study)
3. Post-Hoc Analysis of Week 24 Pain Reduction and TNF-alpha Changes Following Intra-Articular Tissuegene-C (TG-C) in a Knee Osteoarthritis Randomized Trial.
4. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis
5. Levels of extracellular matrix metabolites are associated with changes in Ankylosing Spondylitis Disease Activity Score and MRI inflammation scores in patients with axial spondyloarthritis during TNF inhibitor therapy
6. Development of a highly sensitive chemiluminescence immunoassay for quantification of aggrecanase-generated ARGS aggrecan fragments in serum
7. Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkers
8. Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkers
9. A low cartilage formation and repair endotype predicts radiographic progression of symptomatic knee osteoarthritis
10. Connective tissue remodelling is differently modulated by tocilizumab versus methotrexate monotherapy in patients with early rheumatoid arthritis: the AMBITION study
11. Blood and urine biomarkers in osteoarthritis – an update on cartilage associated type II collagen and aggrecan markers
12. The Janus kinase 1/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis
13. Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis
14. Tissue metabolite of type I collagen, C1M, and CRP predicts structural progression of rheumatoid arthritis
15. Development and validation of a machine learning-supported strategy of patient selection for osteoarthritis clinical trials: the IMI-APPROACH study
16. In Contrast to Anti-CCP, MMP-Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and a Treatment Response Biomarker
17. Abdominal wall hernias—A local manifestation of systemically impaired quality of the extracellular matrix
18. Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis
19. Incidence of total hip and total knee replacements from the prospective epidemiologic risk factor study: considerations for event driven clinical trial design
20. In Contrast to Anti-CCP, MMP-Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and a Treatment Response Biomarker
21. Serum biomarkers in prednisolone-treated hand osteoarthritis patients
22. Development and use of biochemical markers in osteoarthritis: current update
23. Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27
24. Osteoarthritis endotype discovery via clustering of biochemical marker data
25. The association of the lipid profile with knee and hand osteoarthritis severity: the IMI-APPROACH cohort
26. Osteoarthritis endotype discovery via clustering of biochemical marker data
27. Serum biomarkers in prednisolone-treated hand osteoarthritis patients.
28. Osteoarthritis endotype discovery via clustering of biochemical marker data
29. 728 - Weight loss lead to significant effects on OA pain and function: Do the benefits outweigh the risks?
30. 178 DIFFERENTIATION OF BIOMARKERS OF ARTICULAR CARTILAGE METABOLISM WITH RESPECT TO THEIR SENSITIVITY TO PHYSICAL ACTIVITY
31. 167 Regulatory enablement of molecular endotypes for drug development. Definition of the context of use (COU) and molecular endotype which most urgently will assist in drug development: Stakeholder alignment under the Clinical Trial Symposium (CTS) & OARSI umbrella.
32. 164 COMP-M a potential serological biomarker of Osteoarthritis
33. 163 Single joint tissue destruction biomarkers: Association between Type III collagen degradation and local tissue damage of a single joint
34. 160 Evaluation of biomarkers in patients with potential periprosthetic joint infections after hip and knee arthroplasty
35. 112 - BIOMARKERS FOR EROSIVE VS NON-EROSIVE HAND OSTEOARTHRITIS: THE NOR-HAND COHORT
36. 077 - LONGITUDINAL STABILITY OF MOLECULAR ENDOTYPES OF KNEE OSTEOARTHRITIS PATIENTS FROM THE APPROACH COHORT
37. Neuropathic pain in the IMI-APPROACH knee osteoarthritis cohort: prevalence and phenotyping
38. Blood and urine biomarkers in osteoarthritis – an update on cartilage associated type II collagen and aggrecan markers
39. The collagen turnover profile is altered in patients with inguinal and incisional hernia
40. Association Between Experimental Pain Biomarkers and Serologic Markers in Patients With Different Degrees of Painful Knee Osteoarthritis
41. Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study
42. Objective and noninvasive biochemical markers in rheumatoid arthritis:where are we and where are we going?
43. Connective tissue remodelling is differently modulated by tocilizumab versus methotrexate monotherapy in patients with early rheumatoid arthritis:the AMBITION study
44. Neuropathic Pain in the IMI-APPROACH Knee Osteoarthritis Cohort: Prevalence and Phenotyping
45. Neuropathic pain in the IMI-APPROACH knee osteoarthritis cohort: prevalence and phenotyping
46. Serological Biomarkers of Joint Tissue Turnover Predict Tocilizumab Response at Baseline
47. Meta-analysis identifies loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide significance
48. Alpha C-Telopeptide of Type I Collagen Is Associated With Subchondral Bone Turnover and Predicts Progression of Joint Space Narrowing and Osteophytes in Osteoarthritis
49. Biomarkers of cartilage and surrounding joint tissue
50. Objective and noninvasive biochemical markers in rheumatoid arthritis: where are we and where are we going?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.